Home
|
Inbox
|
Search
|
Event
Up to Four Years of Longitudinal Follow-Up for Patients with Severe Eosinophilic Asthma Receiving Reslizumab [Board No. P901]
Location: Board no. P901
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM
Speaker(s)/Author(s)
View Abstract
Parent Sessions
05-20-2018 9:15 AM - 4:15 PM
|
Home
|
Inbox
|
Search
|